Mini-Focus Issue: Natriuretic PeptideEffect of Neprilysin Inhibition on Various Natriuretic Peptide Assays

Add time:08/31/2019    Source:sciencedirect.com

BackgroundWith sacubitril/valsartan treatment, B-type natriuretic peptide (BNP) concentrations increase; it remains unclear whether change in BNP concentrations is similar across all assays for its measurement. Effects of sacubitril/valsartan on atrial natriuretic peptide (ANP) concentrations in patients are unknown. Lastly, the impact of neprilysin inhibition on mid-regional pro-ANP (MR-proANP), N-terminal pro-BNP (NT-proBNP), proBNP1-108, or C-type natriuretic peptide (CNP) is not well understood.

We also recommend Trading Suppliers and Manufacturers of atrial natriuretic factor (7-23), Pro(10)- (cas 114284-25-2). Pls Click Website Link as below: cas 114284-25-2 suppliers

Prev:Clinical ResearchPro–Atrial Natriuretic Peptide: A Novel Guanylyl Cyclase-A Receptor Activator That Goes Beyond Atrial and B-Type Natriuretic Peptides
Next:The influence of confounders in the analysis of mid-regional pro-atrial natriuretic peptide in patients with chronic heart failure)